Study on the Effect of Radish Sprouts on Short-Chain Fatty Acids and Gut Microbial Diversity in Healthy Individuals
Ru Li,
No information about this author
Xuehong Chen,
No information about this author
Cong Shi
No information about this author
et al.
Foods,
Journal Year:
2025,
Volume and Issue:
14(2), P. 170 - 170
Published: Jan. 8, 2025
This
study
aimed
to
assess
the
impact
of
radish
sprouts
on
gut
microbiota
healthy
individuals.
Radish
sprout
additives,
subjected
short-term
storage
and
steam
treatment,
were
used
intervene
in
an
vitro
culture
human
microbiota.
The
influence
was
evaluated
by
monitoring
short-chain
fatty
acid
(SCFA)
content
proportion
fermentation
broth,
microbial
diversity
assessed
using
16S
rDNA
amplicon
sequencing.
results
indicated
that
produced
a
substantial
amount
SCFA
within
48
h
fermentation,
with
right-skewed
distribution
across
all
groups.
addition
both
digestates
enhanced
Firmicutes
diversity,
while
Bacteroidetes
Proteobacteria
remained
stable
between
control
fresh
30
s
treatment
group
showed
increase
decrease
diversity.
abundance
Bacilli,
Bacillaceae,
Bacillus
significantly
higher
steam-treated
groups
compared
control.
Both
enriched
showing
superior
effects.
These
findings
suggest
consumption
may
positively
microbiota,
potentially
enhancing
these
benefits.
Language: Английский
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
MedComm,
Journal Year:
2025,
Volume and Issue:
6(3)
Published: March 1, 2025
Hepatocellular
carcinoma
(HCC)
is
a
leading
cause
of
cancer-related
mortality
globally,
predominantly
associated
with
chronic
hepatitis
B
virus
(HBV)
and
C
(HCV)
infections.
These
infections
drive
persistent
liver
inflammation,
culminating
in
cellular
dysregulation,
fibrosis,
cancer.
Despite
advancements
targeted
therapies,
drug
resistance
the
lack
reliable
biomarkers
for
patient
stratification
still
terribly
hinder
treatment
viral
HCC.
To
this
end,
review
delves
into
intricate
mechanisms
underlying
malignant
transformation
to
HCC,
including
integration,
genomic
instability,
epigenetic
modifications,
oxidative
stress,
gut
microbiota
dysbiosis,
immune
escape,
abnormal
signaling
pathways,
highlighting
their
complex
interactions
synergies.
Cutting-edge
preclinical
clinical
HCC
management,
lifestyle
immunotherapies,
gene-based
approaches,
innovative
treatments,
are
further
investigated,
particular
priority
given
therapeutic
potential
future
applications
overcoming
current
limitations.
By
synthesizing
recent
scientific
insights,
aims
deepen
understanding
pathogenesis
context
hepatitis,
paving
way
novel
targets
personalized
strategies,
ultimately
improving
outcomes.
Language: Английский
A Pilot Study on Qualitative Metabolomics to Characterize Lewis Lung Carcinoma in Mice
Life,
Journal Year:
2025,
Volume and Issue:
15(2), P. 202 - 202
Published: Jan. 29, 2025
Metabolomics
is
a
powerful
tool
that
can
be
used
to
identify
different
stages
in
cancer
development.
In
this
study,
the
metabolomic
profile
of
Lewis
lung
carcinoma
(LLC)
was
characterized
C57BL/6
mice
bearing
LLC
tumors.
Magnetic
resonance
spectroscopy
(nuclear
magnetic
resonance—NMR)
applied
using
400
MHz
1H
NMR
spectrometer.
Two
types
metabolites
(polar
and
non-polar)
were
identified
on
based
analysis
methanol/water
chloroform
extracts
collected
from
samples
mice.
The
investigated
metabolomics
show
neoplastic
processes
growing
may
affect
carbohydrate;
alanine
glutamate;
leucine
isoleucine;
lysine;
creatine;
choline
metabolism,
whereas
hypoxia
states
due
elevated
lactate
tissues.
could
considered
valuable
biomarker
translational
research.
Language: Английский
Anticancer Potential of Prebiotics: Targeting Estrogen Receptors and PI3K/AKT/mTOR in Breast Cancer
Hussein Sabit,
No information about this author
Sama Abouelnour,
No information about this author
Bassel M. Hassen
No information about this author
et al.
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(4), P. 990 - 990
Published: April 18, 2025
Estrogen
receptors
(ERs)
play
a
critical
role
in
breast
cancer
(BC)
development
and
progression,
with
ERα
being
oncogenic
ERβ
exhibiting
tumor-suppressive
properties.
The
interaction
between
ER
signaling
other
molecular
pathways,
such
as
PI3K/AKT/mTOR,
influences
tumor
growth
endocrine
resistance.
Emerging
research
highlights
the
of
prebiotics
modulating
gut
microbiota,
which
may
influence
estrogen
metabolism,
immune
function,
therapeutic
responses
BC.
This
review
explores
impact
on
receptor
modulation,
microbiota
composition,
regulation,
metabolic
pathways
cancer.
potential
adjunctive
therapies
to
enhance
treatment
efficacy
mitigate
chemotherapy-related
side
effects
is
discussed.
A
comprehensive
analysis
recent
preclinical
clinical
studies
was
conducted,
examining
reprogramming
short-chain
fatty
acids
(SCFAs)
derived
from
prebiotic
fermentation
epigenetic
regulation
resistance
also
evaluated.
Prebiotics
were
found
modulate
microbiota-estrogen
axis,
reduce
inflammation,
responses.
SCFAs
demonstrated
selective
downregulation
reprogramming,
suppressing
growth.
Synbiotic
interventions
effects,
improving
quality
life
patients.
offer
promising
avenue
for
prevention
therapy
by
pathways.
Future
trials
are
needed
validate
their
treatments
management.
Language: Английский
Long-Term Exposure to Microplastics Promotes Early-Stage Hepatocarcinogenesis Induced by Diethylnitrosamine in Rats by Modulation of Their Gut Microbiota
Huina Guo,
No information about this author
Jianan Wang,
No information about this author
Shaowen Huang
No information about this author
et al.
Toxics,
Journal Year:
2025,
Volume and Issue:
13(5), P. 353 - 353
Published: April 29, 2025
Hepatocarcinogenesis
is
linked
to
environmental
factors,
with
microplastics
(MPs)
emerging
as
a
global
concern
that
may
contribute
liver
injury.
However,
the
impact
of
MPs
on
early
stages
hepatocarcinogenesis
has
been
largely
ignored.
Here
we
investigated
long-term
MP
exposure
formation
preneoplastic
lesions
during
induced
by
diethylnitrosamine
(DEN)
in
rats.
Rats
were
injected
DEN
induce
lesions,
and
then
they
orally
administered
1
µm
0.5
mg/kg
body
weight
per
day
for
20
weeks.
The
results
revealed
did
not
glutathione
S-transferase
placental
form
(GST-P)-positive
foci
these
animals,
thereby
indicating
non-carcinogenicity.
resulted
1-fold
increase
both
number
size
GST-P-positive
rats
initiated
compared
those
treated
alone.
Accordingly,
led
0.61-fold
index
proliferating
cell
nuclear
antigen
(PCNA)-positive
cells
DEN-initiated
when
treatment
In
addition,
composition
gut
microbiota
was
significantly
altered,
accompanied
various
levels
short-chain
fatty
acids.
Our
suggest
can
promote
pre-neoplastic
lesion
DEN-induced
increased
proliferation
well
alterations
acid
levels.
This
highlights
potential
health
risks
associated
MPs.
Language: Английский
The effects of a modified Mediterranean diet on gut microbiota and clinical outcomes in patients with metastatic colorectal cancer undergoing first-line chemotherapy with either anti-EGFR or anti-VEGF agent: protocol for a randomized pilot study (Preprint)
Salvatore Artale,
No information about this author
Francesca Filiali,
No information about this author
Elena Beretta
No information about this author
et al.
Published: Feb. 21, 2025
BACKGROUND
the
gut
microbiota
is
attracting
increasing
interest
as
an
initiator
of
colorectal
cancer.
It
has
been
observed
that
microbial
imbalance
in
and
cancer
tissue
facilitated
by
a
Western
type
diet,
rich
meat,
sugars,
refined
grains,
while
Mediterranean
low
saturated
fat
fibers,
promotes
eubiosis,
results
reduced
risk
developing
OBJECTIVE
to
analyze
compare
patients
with
metastatic
undergoing
first-line
chemotherapy
+/-
biological
agent
(anti-EGFR
or
anti-VEGF),
receiving
either
free
standard
modified
diet.
METHODS
this
pilot
non-drug,
interventional
prospective,
randomized,
controlled,
single-center,
open-label
trial.
Patients
(n=40)
will
be
randomized
1:1
diet
Blood
fecal
samples
collected
at
baseline
control
visits,
for
metagenomic
metabolomic
analysis.
The
primary
endpoint
Firmicutes/Bacteroidetes
ratio
after
completion
third
cycle
(time
T1).
Secondary
endpoints
are:
a)
percentage
experiencing
gastrointestinal
side
effects
T1;
b)
grade
3/4
c)
changes
ratio,
overall
microbiome
composition,
metabolome
T1,
sixth
(T2)
versus
baseline.
RESULTS
trial
received
ethics
approval
on
July
24th
2024.
By
January
2025,
7
participants
have
recruited.
study
conclude
visit
T2
last
enrolled
patient.
Results
are
expected
published
October
2028.
CONCLUSIONS
potential
provide
critical
insights
into
role
modifying
microbiota,
diminishing
chemotherapy-related
effects,
possibly
enhancing
therapeutic
efficacy
Additionally,
data
may
pave
way
future
research
immunotherapy,
potentially
influencing
both
clinical
practice
public
health
strategies.
CLINICALTRIAL
Clinicaltrial.gov
NCT06794931
(https://clinicaltrials.gov/search?term=NCT06794931)
Language: Английский
Current status and future perspectives of immunotherapy for abdominal liposarcoma: From basic research to clinical practice
Aobo Zhuang,
No information about this author
Zhe Xi,
No information about this author
Ying Cheng
No information about this author
et al.
Shijie huaren xiaohua zazhi,
Journal Year:
2025,
Volume and Issue:
33(2), P. 81 - 88
Published: Feb. 28, 2025
Language: Английский
Immunoregulatory Effects of Codonopsis pilosula Polysaccharide Modified Selenium Nanoparticles on H22 Tumor-Bearing Mice
Yan Long,
No information about this author
Hongfei Ji,
No information about this author
Jiajing Yang
No information about this author
et al.
Foods,
Journal Year:
2024,
Volume and Issue:
13(24), P. 4073 - 4073
Published: Dec. 17, 2024
Codonopsis
pilosula
polysaccharide
(CPP)
and
rare
element
selenium
(Se)
have
been
proved
to
exert
various
biological
activities,
our
previous
study
demonstrated
that
nanoparticles
modified
with
CPP
(CPP-SeNPs)
possessed
significantly
enhanced
tumor
cytotoxicity
in
vitro.
This
aimed
investigated
the
inhibitory
effects
of
CPP-SeNPs
complex
on
H22
solid
tumors
via
immune
enhancement.
In
this
study,
tumor-bearing
mice
model
was
constructed,
potential
mechanisms
antitumor
were
further
explored
by
evaluating
cytokines
expression
levels,
cells
activities
apoptotic
indicators
each
group.
The
results
effectively
exerted
dose-dependent
protective
organs
vivo,
leading
increase
peripheral
white
blood
cell
counts
inhibition
growth
rate
47.18%
high-dose
group
(1.5
mg/kg).
Furthermore,
treatment
elevated
levels
TNF-α,
IFN-γ,
IL-2
sera,
NK
cytotoxicity,
augmented
macrophage
phagocytosis
capacity,
as
well
increased
both
amounts
proliferation
activity
lymphocyte
subsets.
improved
system’s
ability
clear
up-regulating
Bax
while
down-regulating
Bcl-2
within
tumors,
indicating
activation
mitochondrial
apoptosis
pathway.
Therefore,
administration
can
inhibit
enhancing
response
mice,
which
might
be
relevant
regulation
gut
microbiota
short-chain
fatty
acids
metabolisms.
These
findings
could
provide
theoretical
support
data
foundation
for
development
functional
food
drug
adjuvants.
Language: Английский